As of Mar 29
| -0.0039 / -0.90%|
The 5 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 3.00 and a low estimate of 0.80. The median estimate represents a +132.61% increase from the last price of 0.43.
The current consensus among 5 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.